Table 3.

Baseline and post-treatment VA by eyes affected for HIV-positive patients with CMVR treated at MTY Clinic, Myanmar, 2013–2017

	Total (N = 72)		Local treatment (N = 31)		Systemic treatment (N = 41)
	Pre-Rx N (%)	Post-Rx N (%)	Pre-Rx N (%)	Post-Rx N (%)	Pre-Rx N (%)	Post-Rx N (%)
Mild/none	53 (74)	44 (61)	24 (77)	16 (52)	29 (71)	28 (68)
Moderate	9 (12.5)	6 (8)	2 (6)	3 (10)	7 (17)	3 (7)
Severe	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)
Blind	9 (12.5)	7 (10)	5 (16)	5 (16)	4 (10)	2 (5)
Unknown	1 (1)	4 (6)	0 (0)	1 (3)	1 (2)	3 (7)
Deceased/LTFU	0 (0)	11 (15)	0 (0)	6 (19)	0 (0)	5 (12)

CMVR Cytomegalovirus retinitis; LTFU Lost to follow-up; MTY Mittar Yeik; Rx Treatment.